3 H]thymidine uptake and cell proliferation was completely abolished if activation of cPLA 2 was prevented. The response of macrophages to ␣ 2 M* requires transcription factors nuclear factor B, and cAMP-responsive element-binding protein as well as expression of the proto-oncogenes c-fos and c-myc. These studies indicate that the activation of cPLA 2 plays a crucial role in ␣ 2 M*-induced mitogenesis and cell proliferation.The plasma proteinase inhibitor ␣ 2 -macroglobulin (␣ 2 M*) 1 undergoes a major conformational change when it binds proteinases (1, 2). Each ␣ 2 M subunit also contains an internal thiol ester, which can be directly attacked by small nucleophiles resulting in a similar conformational change (1). In either event, receptor recognition sites are exposed in each of the subunits (1). These receptor-recognized forms of ␣ 2 M, termed ␣ 2 M*, bind to the low density lipoprotein receptorrelated protein (LRP) present on a variety of cells including macrophages (1-3). In 1993, we demonstrated that the binding of ␣ 2 M* to macrophages activated signaling cascades characterized by an inositol 1,4,5-trisphosphate (IP 3 )-dependent increase in [Ca 2ϩ ] i (4). Subsequent studies demonstrated that the binding to macrophages activates a pertussis toxin-insensitive phospholipase C, which hydrolyzes membrane phosphoinositides generating both IP 3 and diacylglycerol (5, 6). These studies also demonstrated that ␣ 2 M*-mediated signal transduction was not blocked by addition of receptor-associated protein (RAP). Because RAP blocks the binding of all known ligands to LRP, this observation suggested the presence of a second ␣ 2 M* receptor on macrophages, which was termed the ␣ 2 M* signaling receptor (␣ 2 MSR) (1, 5, 6). In support of the identification of a distinct ␣ 2 M* receptor were several other observations. Two classes of binding sites were identified on macrophages, one of high affinity and low capacity (K d ϳ 50 pM and ϳ1600 sites/cell) and the other LRP, which demonstrated lower affinity and higher binding capacity (K d ϳ2-5 nM and ϳ70,000 sites/cell) (7-10). Binding of other ligands to LRP, moreover, initiated signaling cascades that activated a pertussis toxin-sensitive G protein and were blocked by addition of RAP (4 -12). More recent observations, however, suggest that ␣ 2 M*-mediated signal transduction requires the presence of LRP on cells (13). Thus, Backsai et al. (13) have shown that ␣ 2 M* binding to LRP on neuronal cells mediates signaling via N-methyl-D-aspartate receptors. These authors suggest that an adapter protein causes LRP to associate with this receptor, allowing ␣ 2 M* to activate signal transduction. Furthermore, Herz and colleagues (14, 15) have identified a large number of adapter proteins that can associate with LRP, and Barnes et al. (16) have demonstrated that Tyr-phosphorylated LRP associates with the adapter protein SHC in SRC-transformed cells.Based on our observations with respect to activation of the p21 ras -dependent MAPK and PI 3-kinase signaling cascades and subseq...